Healthpeak Properties, Inc. (NYSE:PEAK) Expected to Post Quarterly Sales of $499.99 Million

Wall Street brokerages predict that Healthpeak Properties, Inc. (NYSE:PEAKGet Rating) will post sales of $499.99 million for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Healthpeak Properties’ earnings, with the highest sales estimate coming in at $519.50 million and the lowest estimate coming in at $486.33 million. Healthpeak Properties posted sales of $476.24 million during the same quarter last year, which would suggest a positive year over year growth rate of 5%. The business is scheduled to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that Healthpeak Properties will report full year sales of $2.00 billion for the current financial year, with estimates ranging from $1.92 billion to $2.10 billion. For the next fiscal year, analysts expect that the business will report sales of $2.11 billion, with estimates ranging from $1.97 billion to $2.29 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Healthpeak Properties.

Healthpeak Properties (NYSE:PEAKGet Rating) last posted its quarterly earnings data on Tuesday, May 3rd. The company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.29). Healthpeak Properties had a net margin of 22.11% and a return on equity of 4.22%. The firm had revenue of $498.40 million during the quarter, compared to analysts’ expectations of $490.02 million. During the same period in the previous year, the company earned $0.40 earnings per share. The business’s quarterly revenue was up 9.5% on a year-over-year basis.

PEAK has been the subject of several research analyst reports. Morgan Stanley dropped their target price on shares of Healthpeak Properties from $35.50 to $34.50 and set an “equal weight” rating for the company in a research report on Monday, March 7th. Credit Suisse Group lifted their target price on Healthpeak Properties from $37.00 to $38.00 and gave the stock a “neutral” rating in a research report on Monday, April 4th. Finally, Bank of America cut Healthpeak Properties from a “buy” rating to a “neutral” rating and set a $32.00 price objective on the stock. in a research note on Thursday, May 19th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $36.39.

Several large investors have recently added to or reduced their stakes in the stock. Eaton Vance Management lifted its position in shares of Healthpeak Properties by 6,049.9% in the third quarter. Eaton Vance Management now owns 614,256 shares of the company’s stock worth $20,597,000 after purchasing an additional 604,268 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in Healthpeak Properties by 6.4% during the fourth quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 87,762 shares of the company’s stock valued at $3,167,000 after purchasing an additional 5,313 shares during the last quarter. Capitolis Advisors LLC increased its position in Healthpeak Properties by 48.5% in the 3rd quarter. Capitolis Advisors LLC now owns 356,283 shares of the company’s stock worth $12,331,000 after purchasing an additional 116,283 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth about $5,340,000. Finally, Lazard Asset Management LLC lifted its holdings in shares of Healthpeak Properties by 63.8% during the 4th quarter. Lazard Asset Management LLC now owns 3,565 shares of the company’s stock valued at $128,000 after buying an additional 1,389 shares during the last quarter. Institutional investors and hedge funds own 95.98% of the company’s stock.

PEAK stock opened at $29.50 on Thursday. The company has a current ratio of 0.87, a quick ratio of 0.87 and a debt-to-equity ratio of 0.91. The firm has a 50 day simple moving average of $33.06 and a 200-day simple moving average of $33.67. The company has a market capitalization of $15.92 billion, a P/E ratio of 37.34, a PEG ratio of 2.93 and a beta of 0.73. Healthpeak Properties has a twelve month low of $28.65 and a twelve month high of $37.69.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 20th. Stockholders of record on Monday, May 9th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 6th. This represents a $1.20 annualized dividend and a dividend yield of 4.07%. Healthpeak Properties’s dividend payout ratio is currently 151.90%.

About Healthpeak Properties (Get Rating)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.

Read More

Get a free copy of the Zacks research report on Healthpeak Properties (PEAK)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthpeak Properties (NYSE:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.